市場調査レポート

商品コード

1429013

フローサイトメトリー市場：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Flow Cytometry Market Assessment, By Products and Service, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年02月20日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 223 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 706,410円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 894,786円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,287,236円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.98円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のフローサイトメトリーの市場規模は、2024年～2031年の予測期間中に7.89％のCAGRで拡大し、2023年の50億1,000万米ドルから2031年には92億米ドルに成長すると予測されています。高齢者人口の増加、慢性疾患や感染症の有病率の上昇が、世界のフローサイトメトリー市場の成長を牽引しています。フローサイトメトリーは、免疫学、ウイルス学、分子生物学、がん生物学、感染症モニタリングなど複数の分野に応用できる強力なツールです。さらに、最新技術や製品の開発のための研究開発に対する医療費の増加は、市場をさらに牽引すると期待されています。

フローサイトメトリーにおける技術の進歩や新製品の発売は、業界に大きな影響を与えています。注目すべき進展の1つは、さまざまな企業がスペクトルフローサイトメトリー技術を商業的に発売したことです。これらの進歩は、がん、免疫不全症、感染症などの疾患の有病率増加に対処する上で極めて重要です。個別化医療、創薬、開発において重要な役割を果たすと期待されています。しかし、高度なフローサイトメトリー装置の高価格は依然として課題であり、小規模な研究施設や新興国での利用が制限される可能性があります。さらに、発展途上国や低開発国におけるこれらの技術へのアクセスを改善するための政府の取り組み、複数の大手企業の存在、および高度なフローサイトメトリー装置や機器を設計するための公開会社と非公開会社の間の継続的な提携が、市場の成長を促進しています。

世界中で慢性疾患や感染症が増加しているため、フローサイトメトリーに対する需要が急増しています。フローサイトメトリーは、がん、HIV、AIDS、結核、その他多くの疾患の検出と分析において重要な役割を果たしています。フローサイトメトリーの精度と感度に関する医療専門家の意識の高まりが業界の成長に寄与しています。

WHOの2023年統計によると、慢性疾患は世界レベルで毎年4,100万人の死亡の原因となっています。これは地域や国に関係なく、あらゆる年齢層の人々に影響を及ぼします。座りっぱなしのライフスタイル、不健康な食事、過度のタバコやアルコール摂取は、慢性疾患の有病率上昇の主要な危険因子です。疾病とその原因物質の早期診断、正確な発見、早期介入は、慢性疾患の蔓延拡大に対抗する唯一の解決策です。そのため、ヘルスケアの専門家はフローサイトメトリーなどの高度な技術や非常に効率的な検査オプションを使用することが可能になり、これが大きな成長促進要因となっています。

当レポートでは、世界のフローサイトメトリー市場について調査し、市場の概要とともに、製品・サービス別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 4. Global Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 5. Global Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 6. Global Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 7. Global Flow Cytometry Market Share (%), By Region, 2017-2031F
Figure 8. North America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 11. North America Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 12. North America Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 13. North America Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 14. North America Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 15. United States Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 18. United States Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 19. United States Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 20. United States Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 24. Canada Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 25. Canada Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 26. Canada Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 30. Mexico Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 31. Mexico Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 36. Europe Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 37. Europe Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 38. Europe Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 40. Germany Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 43. Germany Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 44. Germany Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 45. Germany Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 46. France Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 49. France Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 50. France Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 51. France Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 55. Italy Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 56. Italy Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 57. Italy Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 61. United Kingdom Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 62. United Kingdom Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 67. Russia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 68. Russia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 69. Russia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 73. Netherlands Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 74. Netherlands Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 79. Spain Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 80. Spain Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 81. Spain Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 85. Turkey Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 86. Turkey Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 91. Poland Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 92. Poland Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 93. Poland Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 94. South America Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 97. South America Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 98. South America Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 99. South America Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 100. South America Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 104. Brazil Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 105. Brazil Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 110. Argentina Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 111. Argentina Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 116. Asia-Pacific Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 117. Asia-Pacific Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 120. India Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 123. India Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 124. India Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 125. India Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 126. China Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 129. China Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 130. China Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 131. China Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 135. Japan Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 136. Japan Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 137. Japan Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 141. Australia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 142. Australia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 143. Australia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 147. Vietnam Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 148. Vietnam Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 153. South Korea Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 154. South Korea Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 159. Indonesia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 160. Indonesia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 165. Philippines Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 166. Philippines Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 171. Middle East & Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 172. Middle East & Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Flow Cytometry Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 178. Saudi Arabia Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 179. Saudi Arabia Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 184. UAE Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 185. UAE Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 186. UAE Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Flow Cytometry Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Flow Cytometry Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Flow Cytometry Market Share (%), By Product and Service, 2017-2031F
Figure 190. South Africa Flow Cytometry Market Share (%), By Technology, 2017-2031F
Figure 191. South Africa Flow Cytometry Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Flow Cytometry Market Share (%), By End-user, 2017-2031F
Figure 193. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11009

Global flow cytometry market is projected to witness a CAGR of 7.89% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 9.2 billion in 2031. The increasing geriatric population and the rising prevalence of chronic and infectious diseases drive growth in the global flow cytometry market. Flow cytometry is a powerful tool with applications in multiple disciplines such as immunology, virology, molecular biology, cancer biology, and infectious disease monitoring. Moreover, increasing healthcare expenditure on research and development for the development of the latest technologies and products is further expected to drive the market.

Technological advancements and new product launches in flow cytometry have significantly impacted the industry. One notable development is various companies' commercial launch of spectral flow cytometry technology. These advancements are crucial in addressing the increasing prevalence of diseases, such as cancer, immunodeficiency disorders, and infectious diseases. They are expected to play a vital role in personalized medicine, drug discovery, and development. However, the high cost of advanced flow cytometry equipment remains challenging, potentially limiting accessibility for smaller research facilities or emerging countries. Moreover, government initiatives for improving access to these technologies in developing and under-developed countries, the presence of several leading players, and ongoing partnerships between public and private companies for engineering advanced flow cytometry devices and instruments are facilitating market growth.

Increasing Prevalence of Chronic and Infectious Diseases

There has been a surge in the demand for flow cytometry due to the rising number of chronic and infectious diseases worldwide. Flow cytometry plays a crucial role in detecting and analyzing diseases such as cancer, HIV, AIDS, TB, and many more. Rising awareness among healthcare professionals regarding the accuracy and sensitivity of flow cytometry is contributing to industry growth.

According to WHO 2023 statistics, chronic diseases are responsible for 41 million deaths every year at a global level. This affects people of all age groups, irrespective of their region or country. A sedentary lifestyle, unhealthy diet, and excessive tobacco and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases. Early diagnosis, accurate detection, and early intervention of the disease and its disease-causing agents are the only solutions to combat the growing prevalence of chronic diseases. This, in turn, enables healthcare professionals to use advanced technologies and highly efficient testing options, such as flow cytometry, acting as a major growth-inducing factor.

Technological Advancements

With a high prevalence of cancer, AIDS, and many other infectious diseases, there is an increasing demand to bring innovation in the flow cytometry industry that can enhance the accuracy of diagnosis and gather insights related to cell structure and functions. Key players are constantly investing in research and development to launch innovative products and instruments to facilitate flow cytometry technological advancements. In June 2023, Becton, Dickinson and Company, a global leader in medical technology, announced that it has launched an innovative automated instrument "BD FACSDuet", that can prepare samples for clinical diagnostics using flow cytometry to improve standardization and reproducibility in cellular diagnostics. The entire sample preparation process, including cocktailing, washing, and centrifuging, is automated by this product. These samples are then transferred to the physically integrated BD FACSLyric clinical flow cytometry system without any human intervention.

Government Initiatives

Government initiatives are playing a significant role in supporting the field of flow cytometry. One notable example is the establishment of the NIST Flow Cytometry Standards Consortium, which brings together industry, academia, and government to identify and address measurement and standard needs across the flow cytometry field. Additionally, government support through funds, grants, and public-private partnerships is contributing to the growth of the flow cytometry market, particularly in the context of research activities such as cancer, stem cell, and HIV studies. These initiatives are crucial in advancing the field of flow cytometry and addressing standardization issues, ultimately contributing to the development of new and innovative technologies in the market.

In August 2022, NanoCellect Biomedical Inc., a leader in developing and manufacturing microfluidic cells, announced that it received a grant of USD 1.8 million from Small Business Innovation Research (SBIR). This fund was granted to assist NanoCellect Biomedical Inc. in developing AI-based imaging flow cytometry technology. It would further help in research programs to develop novel imaging flow cytometry technology.

Growth in Demand for Cell Based Flow Cytometry

Among the technology segment, cell-based flow cytometry segment is expected to grow faster. Cell-based flow cytometry offers the advantage of high throughput and the potential to analyze millions of cells. Flow cytometry provides highly detailed information on single cells for immunotherapy clinical trials, enabling the monitoring of immune responses and the detection of abnormal cells. This technology monitors changes in immune cell phenotype, tracks therapeutic cells, and detects abnormal cells, thus offering a comprehensive view of a disease's micro-environment. In May 2023, Becton, Dickinson and Company, announced global commercial launch of an innovative cell sorting instrument, "BD FACSDiscover", a cell-based technology that will enable researchers to get more insights about cells in various areas, such as drug discovery, immuno-oncology and genomics, which is not possible in traditional flow cytometry experiments. BD FACSDiscover allows the investigation of different aspects of single-cell biology and sorts complex phenotypes for immunologic or genetic discovery.

North America Accounts for the Largest Share in Flow Cytometry Market

North America accounted for the largest share of the global flow cytometry market in 2022, with the United States being a major contributor to this dominance. The region's favorable business environment, substantial government support through funds and grants, and a robust healthcare infrastructure have driven its leadership in the flow cytometry market. Additionally, the high prevalence of HIV/AIDS and cancer has led to a growing focus on the development of treatment options for these target diseases, further propelling the demand for flow cytometry technologies.

The strong presence of key regional players, such as BD, Danaher Corporation, and Thermo Fisher Scientific, has also contributed to North America's market leadership. According to the CDC (Center for Disease Control), 6 out of 10 adults in the US are affected by a chronic disease, whereas 4 out of 10 adults in the USA have 2 or more chronic diseases. Thus, the significant prevalence of chronic and infectious diseases in this region will contribute to increased demand for rapid detection and diagnosis by flow cytometry.

Future Outlook of Global Flow Cytometry Market

Global flow cytometry market is expected to grow in the coming years, due to the growing elderly population and the increasing prevalence of infectious and chronic diseases globally. Technological advancements, research and development, government support, increasing healthcare budget, and collaborative ventures involving medical devices manufacturers, research institutions, and other healthcare providers are anticipated to drive the market growth over the forecasted period.

Key Players Landscape and Outlook

In the flow cytometry market, mergers and acquisitions, partnerships, and distribution agreements are pivotal in driving the global market. These alliances empower firms to adapt to each other's strengths, gain access to new markets and technologies, and pool resources for research and development. Distribution agreements enable companies to expand their market presence. These collaborative initiatives promote innovation, expedite product developments, and contribute to the development and growth of the global flow cytometry market. In February 2023, Luminex Corporation signed an agreement to sell all its flow cytometry & imaging (FCI) business unit assets to Cytek Biosciences. With this strategic acquisition, the company would gain insights into all facets of cellular phenotypes and morphology. There are more than 7,000 instruments, which will be under the Cytek umbrella following this acquisition that will further expand the company's global presence.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Flow Cytometry Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. Value
- 4.1.2. Volume
4.2. By Products and Service
- 4.2.1. Instruments
  - 4.2.1.1. Cell Analysers
  - 4.2.1.2. Cell Sorters
- 4.2.2. Kits and Reagents
- 4.2.3. Software and Services
- 4.2.4. Others
4.3. By Technology
- 4.3.1. Cell-based Flow Cytometry
- 4.3.2. Bead-based Flow Cytometry
4.4. By Application
- 4.4.1. Oncology
- 4.4.2. Drug Discovery
- 4.4.3. Stem Cell Therapy
- 4.4.4. Hematology
- 4.4.5. Immunology
- 4.4.6. Other applications
4.5. By End-user
- 4.5.1. Hospitals
- 4.5.2. Clinical Testing Laboratories
- 4.5.3. Academic & Research Institutes
- 4.5.4. Others
4.6. By Region
- 4.6.1. North America
- 4.6.2. Europe
- 4.6.3. South America
- 4.6.4. Asia-Pacific
- 4.6.5. Middle East and Africa
4.7. By Company Market Share (%), 2023

5. Global Flow Cytometry Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. Value
  - 5.1.1.2. Volume
- 5.1.2. By Product and Services
  - 5.1.2.1. Instruments
  - 5.1.2.1.1. Cell Analysers
  - 5.1.2.1.2. Cell Sorters
  - 5.1.2.2. Kits and Reagents
  - 5.1.2.3. Software and Services
  - 5.1.2.4. Others
- 5.1.3. By Technology
  - 5.1.3.1. Cell-based Flow Cytometry
  - 5.1.3.2. Bead-based Flow Cytometry
- 5.1.4. By Application
  - 5.1.4.1. Oncology
  - 5.1.4.2. Drug Discovery
  - 5.1.4.3. Stem Cell Therapy
  - 5.1.4.4. Hematology
  - 5.1.4.5. Immunology
  - 5.1.4.6. Other applications
- 5.1.5. By End-user
  - 5.1.5.1. Hospitals
  - 5.1.5.2. Clinical Testing Laboratories
  - 5.1.5.3. Academic & Research Institutes
  - 5.1.5.4. Others
- 5.1.6. United States*
  - 5.1.6.1. Market Size & Forecast
  - 5.1.6.1.1. Value
  - 5.1.6.1.2. Volume
  - 5.1.6.2. By Product and Services
  - 5.1.6.2.1. Instruments
  - 5.1.6.2.1.1. Cell Analysers
  - 5.1.6.2.1.2. Cell Sorters
  - 5.1.6.2.2. Kits and Reagents
  - 5.1.6.2.3. Software and Services
  - 5.1.6.2.4. Others
  - 5.1.6.3. By Technology
  - 5.1.6.3.1. Cell-based Flow Cytometry
  - 5.1.6.3.2. Bead-based Flow Cytometry
  - 5.1.6.4. By Application
  - 5.1.6.4.1. Oncology
  - 5.1.6.4.2. Drug Discovery
  - 5.1.6.4.3. Stem Cell Therapy
  - 5.1.6.4.4. Hematology
  - 5.1.6.4.5. Immunology
  - 5.1.6.4.6. Other applications
  - 5.1.6.5. By End-user
  - 5.1.6.5.1. Hospitals
  - 5.1.6.5.2. Clinical Testing Laboratories
  - 5.1.6.5.3. Academic & Research Institutes
  - 5.1.6.5.4. Others
- 5.1.7. Canada
- 5.1.8. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product and Services
6.2. By Technology
6.3. By Application
6.4. By End-user
6.5. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Becton, Dickinson and Company
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. Thermo Fisher Scientific
13.3. Bio-Rad Laboratories, Inc.
13.4. Miltenyi Biotec B.V. & Co. KG
13.5. Sysmex Asia Pacific Pte Ltd.
13.6. Agilent Technologies, Inc.
13.7. Sony Biotechnology Inc. LLC
13.8. Enzo Life Sciences, Inc.
13.9. Cytek Biosciences, Inc.
13.10. Sartorius AG
13.11. Apogee Flow Systems Ltd.
13.12. Luminex Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

フローサイトメトリー市場：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Flow Cytometry Market Assessment, By Products and Service, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のフローサイトメトリー市場の見通し、2017年～2031年

第5章世界のフローサイトメトリー市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Flow Cytometry Market Outlook, 2017-2031F

5. Global Flow Cytometry Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

フローサイトメトリー市場：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Flow Cytometry Market Assessment, By Products and Service, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のフローサイトメトリー市場の見通し、2017年～2031年

第5章 世界のフローサイトメトリー市場の見通し、地域別、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 お問合せと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Flow Cytometry Market Outlook, 2017-2031F

5. Global Flow Cytometry Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のフローサイトメトリー市場の見通し、2017年～2031年

第5章世界のフローサイトメトリー市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項